Obesity and polycystic ovary syndrome

被引:348
|
作者
Barber, T. M.
McCarthy, M. I.
Wass, J. A. H.
Franks, S.
机构
[1] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford, England
[2] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Dept Endocrinol, Oxford, England
[3] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England
关键词
D O I
10.1111/j.1365-2265.2006.02587.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aetiology of Polycystic Ovary Syndrome (PCOS) is complex and multifactorial. There is much evidence, however, to suggest that adipose tissue plays an important role in the development and maintenance of PCOS pathology. There is a close correlation between adiposity and symptom severity in women with PCOS, and even modest reductions in weight generally translate into significant improvements in menstrual regularity, fertility and hyperandrogenic features. This review article considers the various mechanisms that might underlie this link between excess adiposity and PCOS - including the effects of differential insulin sensitivity, abnormal steroid hormone metabolism and adipocytokine secretion. Greater attention to the therapeutic options available to reduce the impact of excess adiposity on ovarian and metabolic function is essential to the management of PCOS.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [41] Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
    Lopez-Alarcon, Mardia
    Vital-Reyes, Victor Saul
    Almeida-Gutierrez, Eduardo
    Maldonado-Hernandez, Jorge
    Flores-Chavez, Salvador
    Dominguez-Salgado, Juan Manuel
    Vite-Bautista, Jose
    Cruz-Martinez, David
    Barradas-Vazquez, Aly S.
    Z'Cruz-Lopez, Ricardo
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
  • [42] Obesity and insulin resistance in women with polycystic ovary syndrome
    Hsu Chun-Sen
    Wu Chien-Hua
    Chiu Wan-Chun
    Lee Ching-Tzu
    Chang Chun-Jen
    Hsu Ming-, I
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (05) : 300 - 306
  • [43] Pathogenesis of polycystic ovary syndrome: What is the role of obesity?
    Salehi, M
    Bravo-Vera, R
    Sheikh, A
    Gouller, A
    Poretsky, L
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (03): : 358 - 376
  • [44] The impact of obesity on reproduction in women with polycystic ovary syndrome
    Pasquali, R.
    Gambineri, A.
    Pagotto, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (10) : 1148 - 1159
  • [45] Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
    Moran, Carlos
    Arriaga, Monica
    Rodriguez, Gustavo
    Moran, Segundo
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2012, 2012
  • [46] Obesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy
    Kathleen M. Hoeger
    Current Obesity Reports, 2012, 1 (4) : 191 - 198
  • [47] Coagulation factor dysregulation in polycystic ovary syndrome is an epiphenomenon of obesity
    Moin, Abu Saleh Md
    Sathyapalan, Thozhukat
    Butler, Alexandra E.
    Atkin, Stephen L.
    CLINICAL ENDOCRINOLOGY, 2023, 98 (06) : 796 - 802
  • [48] Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome
    Hernandez-Mijares, Antonio
    Banuls, Celia
    Gomez-Balaguer, Marcelino
    Bergoglio, Marina
    Victor, Victor M.
    Rocha, Milagros
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (06) : 549 - 556
  • [49] Obesity and Outcome of Assisted Reproduction in Patients with Polycystic Ovary Syndrome
    Tziomalos, Konstantinos
    Dinas, Konstantinos
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [50] Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome
    Aytan, Asli Nehir
    Bastu, Ercan
    Demiral, Irem
    Bulut, Huri
    Dogan, Murat
    Buyru, Faruk
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (09) : 709 - 713